Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Glutamate transport system as a key constituent of glutamosome: Molecular pathology and pharmacological modulation in chronic pain.

Gegelashvili G, Bjerrum OJ.

Neuropharmacology. 2019 Apr 29:107623. doi: 10.1016/j.neuropharm.2019.04.029. [Epub ahead of print] Review.

PMID:
31047920
2.

The β-lactam clavulanic acid mediates glutamate transport-sensitive pain relief in a rat model of neuropathic pain.

Kristensen PJ, Gegelashvili G, Munro G, Heegaard AM, Bjerrum OJ.

Eur J Pain. 2018 Feb;22(2):282-294. doi: 10.1002/ejp.1117. Epub 2017 Oct 6.

PMID:
28984398
3.

Glutamate Transport System as a Novel Therapeutic Target in Chronic Pain: Molecular Mechanisms and Pharmacology.

Gegelashvili G, Bjerrum OJ.

Adv Neurobiol. 2017;16:225-253. doi: 10.1007/978-3-319-55769-4_11. Review.

PMID:
28828613
4.

High-affinity glutamate transporters in chronic pain: an emerging therapeutic target.

Gegelashvili G, Bjerrum OJ.

J Neurochem. 2014 Dec;131(6):712-30. doi: 10.1111/jnc.12957. Epub 2014 Oct 26. Review.

5.

Limited energy supply in Müller cells alters glutamate uptake.

Toft-Kehler AK, Skytt DM, Poulsen KA, Brændstrup CT, Gegelashvili G, Waagepetersen H, Kolko M.

Neurochem Res. 2014 May;39(5):941-9. doi: 10.1007/s11064-014-1289-z. Epub 2014 Apr 4.

PMID:
24700282
6.

Tonic activation of group I mGluRs modulates inhibitory synaptic strength by regulating KCC2 activity.

Banke TG, Gegelashvili G.

J Physiol. 2008 Oct 15;586(20):4925-34. doi: 10.1113/jphysiol.2008.157024. Epub 2008 Sep 4.

7.

Glutamate transporter GLAST/EAAT1 directs cell surface expression of FXYD2/gamma subunit of Na, K-ATPase in human fetal astrocytes.

Gegelashvili M, Rodriguez-Kern A, Sung L, Shimamoto K, Gegelashvili G.

Neurochem Int. 2007 Jun;50(7-8):916-20. Epub 2007 Jan 14.

PMID:
17316900
8.

High-affinity glutamate transporter GLAST/EAAT1 regulates cell surface expression of glutamine/neutral amino acid transporter ASCT2 in human fetal astrocytes.

Gegelashvili M, Rodriguez-Kern A, Pirozhkova I, Zhang J, Sung L, Gegelashvili G.

Neurochem Int. 2006 May-Jun;48(6-7):611-5. Epub 2006 Mar 3.

PMID:
16516348
9.

Expression of glutamate transporter subtypes in cultured retinal pigment epithelial and retinoblastoma cells.

Mäenpää H, Gegelashvili G, Tähti H.

Curr Eye Res. 2004 Mar;28(3):159-65.

PMID:
14977517
10.

GDNF pre-treatment aggravates neuronal cell loss in oxygen-glucose deprived hippocampal slice cultures: a possible effect of glutamate transporter up-regulation.

Bonde C, Sarup A, Schousboe A, Gegelashvili G, Noraberg J, Zimmer J.

Neurochem Int. 2003 Sep-Oct;43(4-5):381-8.

PMID:
12742082
11.

Neurotoxic and neuroprotective effects of the glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) during physiological and ischemia-like conditions.

Bonde C, Sarup A, Schousboe A, Gegelashvili G, Zimmer J, Noraberg J.

Neurochem Int. 2003 Sep-Oct;43(4-5):371-80.

PMID:
12742081
12.
13.

Regulation of glutamate transporters in health and disease.

Gegelashvili G, Robinson MB, Trotti D, Rauen T.

Prog Brain Res. 2001;132:267-86. Review. No abstract available.

PMID:
11544995
14.

Metabolic distinction between vesicular and cytosolic GABA in cultured GABAergic neurons using 13C magnetic resonance spectroscopy.

Waagepetersen HS, Sonnewald U, Gegelashvili G, Larsson OM, Schousboe A.

J Neurosci Res. 2001 Feb 15;63(4):347-55.

PMID:
11170185
15.

The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms.

Gegelashvili G, Dehnes Y, Danbolt NC, Schousboe A.

Neurochem Int. 2000 Aug-Sep;37(2-3):163-70.

PMID:
10812201
16.

Effects of taurine depletion on cell migration and NCAM expression in cultures of dissociated mouse cerebellum and N2A cells.

Maar TE, Lund TM, Gegelashvili G, Hartmann-Petersen R, Moran J, Pasantes-Morales H, Berezin V, Bock E, Schousboe A.

Amino Acids. 1998;15(1-2):77-88.

PMID:
9871488
17.

Cellular distribution and kinetic properties of high-affinity glutamate transporters.

Gegelashvili G, Schousboe A.

Brain Res Bull. 1998;45(3):233-8. Review.

PMID:
9510415
18.
19.

High affinity glutamate transporters: regulation of expression and activity.

Gegelashvili G, Schousboe A.

Mol Pharmacol. 1997 Jul;52(1):6-15. Review.

PMID:
9224806
20.

Role of astrocytes in glutamate homeostasis. Implications for excitotoxicity.

Schousboe A, Sonnewald U, Civenni G, Gegelashvili G.

Adv Exp Med Biol. 1997;429:195-206. Review. No abstract available.

PMID:
9413575
21.

Glutamate receptor agonists up-regulate glutamate transporter GLAST in astrocytes.

Gegelashvili G, Civenni G, Racagni G, Danbolt NC, Schousboe I, Schousboe A.

Neuroreport. 1996 Dec 20;8(1):261-5.

PMID:
9051792
22.

Two types of amyloid precursor protein (APP) mRNA in rat glioma cell lines: upregulation via a cyclic AMP-dependent pathway.

Gegelashvili G, Bock E, Schousboe A, Linnemann D.

Brain Res Mol Brain Res. 1996 Apr;37(1-2):151-6.

PMID:
8738146
23.

Taurine deficiency and neuronal migration.

Morán J, Maar T, Gegelashvili G, Bock E, Schousboe A, Pasantes-Morales H.

Adv Exp Med Biol. 1996;403:519-26. Review. No abstract available.

PMID:
8915390
24.

Expression of amyloid precursor protein (APP) in rat brain and cultured neural cells.

Gegelashvili G, Schousboe A, Linnemann D.

Int J Dev Neurosci. 1994 Dec;12(8):703-8.

PMID:
7747597
25.

Cyclic AMP regulates NCAM expression and phosphorylation in cultured mouse astrocytes.

Gegelashvili G, Andersson AM, Schousboe A, Bock E.

Eur J Cell Biol. 1993 Dec;62(2):343-51.

PMID:
7925490
26.

Characterization of NCAM diversity in cultured neurons.

Gegelashvili G, Andersson AM, Schousboe A, Bock E.

FEBS Lett. 1993 Jun 21;324(3):337-40.

27.

[Fusogenic properties of latrotoxin].

Lishko VK, Terletskaia IaT, Gegelashvili GK.

Dokl Akad Nauk SSSR. 1986;288(3):740-3. Russian. No abstract available.

PMID:
3720508

Supplemental Content

Loading ...
Support Center